Does HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN Cause Off label use? 117 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 117 reports of Off label use have been filed in association with HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN (Cytogam). This represents 30.2% of all adverse event reports for HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN.
117
Reports of Off label use with HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
30.2%
of all HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN reports
58
Deaths
51
Hospitalizations
How Dangerous Is Off label use From HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN?
Of the 117 reports, 58 (49.6%) resulted in death, 51 (43.6%) required hospitalization, and 10 (8.5%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN. However, 117 reports have been filed with the FAERS database.
What Other Side Effects Does HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN Cause?
Drug ineffective (124)
Nephropathy toxic (91)
Myelosuppression (77)
Encephalitis cytomegalovirus (72)
Acute kidney injury (68)
Cytomegalovirus infection reactivation (66)
Pancytopenia (66)
Bk virus infection (64)
Respiratory distress (62)
Cystitis haemorrhagic (61)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN Alternatives Have Lower Off label use Risk?
HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN vs HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN vs HUMAN IMMUNOGLOBULIN G
HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE
HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN
HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN vs HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE, RECOMBINANT